162 related articles for article (PubMed ID: 2268504)
21. Serotonin-induced contraction of canine basilar artery: mediation by 5-HT1 receptors.
Peroutka SJ; Noguchi M; Tolner DJ; Allen GS
Brain Res; 1983 Jan; 259(2):327-30. PubMed ID: 6824943
[TBL] [Abstract][Full Text] [Related]
22. 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery.
Parsons AA; Whalley ET; Feniuk W; Connor HE; Humphrey PP
Br J Pharmacol; 1989 Feb; 96(2):434-40. PubMed ID: 2538194
[TBL] [Abstract][Full Text] [Related]
23. Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction.
MacLennan SJ; Martin GR
Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):120-9. PubMed ID: 2234096
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the response to 5-carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries.
Toda N; Okamura T
J Pharmacol Exp Ther; 1990 May; 253(2):676-82. PubMed ID: 2338652
[TBL] [Abstract][Full Text] [Related]
25. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries.
Cohen RA; Shepherd JT; Vanhoutte PM
Am J Physiol; 1983 Dec; 245(6):H1077-80. PubMed ID: 6660308
[TBL] [Abstract][Full Text] [Related]
26. Presynaptic inhibitory action of 5-hydroxytryptamine in dog isolated saphenous vein.
Feniuk W; Humphrey PP; Watts AD
Br J Pharmacol; 1979 Oct; 67(2):247-54. PubMed ID: 497528
[TBL] [Abstract][Full Text] [Related]
27. 5-HT1-like receptors requiring functional cyclo-oxygenase and 5-HT2 receptors independent of cyclo-oxygenase mediate contraction of the human umbilical artery.
MacLennan SJ; Whittle MJ; McGrath JC
Br J Pharmacol; 1989 Jul; 97(3):921-33. PubMed ID: 2503229
[TBL] [Abstract][Full Text] [Related]
28. Characterization of serotonin receptors in isolated rat intramyocardial coronary artery.
Lai FM; Tanikella T; Cervoni P
J Pharmacol Exp Ther; 1991 Jan; 256(1):164-8. PubMed ID: 1988655
[TBL] [Abstract][Full Text] [Related]
29. Rabbit isolated renal artery contractions by some tryptamine derivatives, including 2-methyl-5-HT, are mediated by a 5-HT1-like receptor.
Tadipatri S; Feniuk W; Saxena PR
Br J Pharmacol; 1992 Oct; 107(2):322-8. PubMed ID: 1422584
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the actions of serotoninergic agents on human saphenous veins and platelets.
Victorzon M; Tapparelli C; Müller-Schweinitzer E
Eur J Pharmacol; 1986 May; 124(1-2):107-11. PubMed ID: 3720831
[TBL] [Abstract][Full Text] [Related]
31. Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors.
Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(2):149-54. PubMed ID: 6136920
[TBL] [Abstract][Full Text] [Related]
32. Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization.
van den Broek RW; Bhalla P; VanDenBrink AM; de Vries R; Sharma HS; Saxena PR
Cephalalgia; 2002 Mar; 22(2):83-93. PubMed ID: 11972574
[TBL] [Abstract][Full Text] [Related]
33. Sumatriptan-induced saphenous venoconstriction in the anaesthetized dog through 5-HT1-like receptor activation.
Drieu la Rochelle C; O'Connor SE
Br J Pharmacol; 1995 Oct; 116(4):2207-12. PubMed ID: 8564250
[TBL] [Abstract][Full Text] [Related]
34. Human isolated coronary artery contraction to sumatriptan characterised by the selective 5-HT1B/1D receptor antagonist GR55562.
Maassen VanDenBrink A; Reekers M; Bax WA; Saxena PR
Pharmacol Toxicol; 2000 Jun; 86(6):287-90. PubMed ID: 10895993
[TBL] [Abstract][Full Text] [Related]
35. Typical and atypical antipsychotic drugs are potent antagonists of the relaxant 5-hydroxytryptamine receptor in the smooth muscle of canine coronary artery.
Terrón JA
Proc West Pharmacol Soc; 1996; 39():23-5. PubMed ID: 8895957
[No Abstract] [Full Text] [Related]
36. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
Cohen ML; Schenck KW; Hemrick-Luecke SH
J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
[TBL] [Abstract][Full Text] [Related]
37. Effects of SL 65.0472, a novel 5-HT receptor antagonist, on 5-HT receptor mediated vascular contraction.
Galzin AM; Delahaye M; Hoornaert C; McCort G; O'Connor SE
Eur J Pharmacol; 2000 Sep; 404(3):361-8. PubMed ID: 10996601
[TBL] [Abstract][Full Text] [Related]
38. Role of 5-HT2 receptors in serotonin-induced contractions of nonvascular smooth muscle.
Cohen ML; Schenck KW; Colbert W; Wittenauer L
J Pharmacol Exp Ther; 1985 Mar; 232(3):770-4. PubMed ID: 3973826
[TBL] [Abstract][Full Text] [Related]
39. 5-Hydroxytryptamine contracts human uterine artery smooth muscle predominantly via 5-HT2 receptors.
Karlsson C; Bodelsson G; Bodelsson M; Stjernquist M
Hum Reprod; 1997 Feb; 12(2):361-7. PubMed ID: 9070726
[TBL] [Abstract][Full Text] [Related]
40. Characterization of 5-hydroxytryptamine receptors mediating circular smooth muscle contraction in the human umbilical artery.
Karlsson C; Bodelsson G; Bodelsson M; Stjernquist M
Gynecol Obstet Invest; 1999; 47(2):102-7. PubMed ID: 9949279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
